| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.0047 | 1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.0043 | 1 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.0041 | 1 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |